In this game of 3D chess, our opponent is becoming more sophisticated, and healthcare organizations must constantly focus on protecting their most valued pieces, their data. The possible ramifications across healthcare are too valuable to let our guard down. The post One Year Post-Change Healthcare Cyber Attack: What Keeps This Healthcare CTO Awake at Night…
Whether creating a health application or platform-based solutions, the effectiveness of innovation in healthtech relies not only on scientifically backed up technology, but more on consumer-driven design, highlighting the need for precision and efficiency. The post From Silos to Synergy: Integrating Clinical Teams into Agile Product Workflows appeared first on MedCity News.
Federal regulators have blocked two private sector enrollment websites from accessing consumer information through the federal Obamacare marketplace, citing “anomalous activity.” The unusual step comes as the Centers for Medicare & Medicaid Services is under the gun to curb unauthorized enrollment and switching of Affordable Care Act plans by rogue agents. The agency received more…
Chuanzi Yue and Marisa Miraldo argue in a recent Health Affairs Forefront piece that the answer is ‘yes’, but I am highly skeptical of their claim. Will IRA cause firms to allocate funds from marketing to R&D? One point they make is that the IRA’s Medicare Drug Price Negotiation program will reduce pharmaceutical expenses on…
What happens when payers don’t comply with contract terms? What if a provider overlooks the fine print? Contracts between healthcare providers and payers are supposed to make each party’s responsibilities crystal clear. The reality is often murky. Providers face expensive consequences if they fail to adhere to payer policies – yet they often struggle to…
Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public by merging with a Cormorant-sponsored SPAC. The combined company will continue developing drugs targeting various forms of mutated KRAS proteins that drive cancers. The post BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs appeared…
Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million. The post Fay Raises $50M to Expand Access to Nutrition Counseling Services appeared first on MedCity News.
Headed into a lame-duck session, the AHA requested Congress to act on key priorities for health systems before the end of 2024
The decline in cognitive health, especially that leading to Alzheimer’s and other brain diseases, is one of the most feared conditions by patients and their families. It’s also one of the most expensive. But if we can predict it early there are things we can do to prevent or ameliorate it. The issue has been…
This brief analyzes federal transparency data released by the Centers for Medicare and Medicaid Services (CMS) on claims denials and appeals for non-group qualified health plans (QHPs) offered on HealthCare.gov in 2023. It finds that HealthCare.gov insurers denied nearly one out of every five claims (19%) submitted for in-network services. Information about the reasons for…